The selective androgen receptor modulator GTx-024 (enobosarm) improves lean body mass and physical function in healthy elderly men and postmenopausal women: results of a double-blind, placebo-controlled phase II trial A 12-week phase II trial of GTx-024 (enobosarm), a selective androgen receptor modulator, in elderly men and postmenopausal women showed dose-dependent increases in lean body mass, improved physical function, and better insulin resistance with a favorable safety profile, suggesting its potential for treating muscle wasting in chronic diseases
[DOI] [PubMed] [Google Scholar] 26.Oliveira L, Macedo M, Rodrigues J, et al
All 11 RP/MRD cell lines showed complete growth and signaling insensitivity to rapamycin but variable sensitivity to bi-steric mTORC1 inhibitors, with Mtor S2035 mutations identified in 4 of 7 RP cell lines
Protein concentration was measured using Eppendorf Biophotometer Plus (Eppendorf.AG)
Reduziertes Eisen und Kupfer, im Vollblut gemessen, weisen ebenfalls auf die mangelnde Entgiftungsfunktion (Eisen) und Nierenschwche (Kupfer) hin